Fulltext

Side effects of CoronaVac® COVID-19 vaccination: Investigation in North Jakarta district public health center communities in Indonesia

Ramatillah DL 1 , Gan SH 2 , Novarticia J 1 , Araminda GN 1 , Michael M 1 , Elnaem M 3 Show all authors , Alawuddin R 1 , Khan K 4

Affiliations 

  • 1 Faculty of Pharmacy, Universitas 17 Agustus 1945, Jakarta, Indonesia
  • 2 School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, 47500, Bandar Sunway, Selangor, Malaysia
  • 3 University of Ulster School of Pharmacy and Pharmaceutical Sciences, Ireland
  • 4 Department of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail, Saudi Arabia
Heliyon, 2024 May 15;10(9):e30087.
PMID: 38694099 DOI: 10.1016/j.heliyon.2024.e30087

Abstract

BACKGROUND: The decreasing prevalence of COVID-19 has highlighted the value of vaccinations. CoronaVac® vaccine was one of the most widely used vaccines in Indonesia, in other Southeast Asian countries, as well as in Latin America. However, to date the safety and side effect profiles of CoronaVac® vaccine among the Indonesian population have not been reported.

OBJECTIVE: In this study, the CoronaVac® safety profiles were determined in a community of a public health center in North Jakarta, Indonesia.

METHOD: This is a descriptive cross-sectional questionnaire-based study on vaccine side effects as recorded in the yellow form (MESO). Patients (n = 300) who received CoronaVac® vaccinations between July and August 2021 were enrolled. SPSS was used to analyze the descriptive data.

RESULTS: Most respondents were women (72.7 %) between the ages of 17 and 21 years. A significantly (p = 0.009) positive correlation was established between the vaccine side effects (namely pain at the injection site) with the female gender. Other side effects such as fatigue (p = 0.034) and headache (p 

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications